Literature DB >> 19007744

The mitochondrial p53 pathway.

Angelina V Vaseva1, Ute M Moll.   

Abstract

p53 is one of the most mutated tumor suppressors in human cancers and as such has been intensively studied for a long time. p53 is a major orchestrator of the cellular response to a broad array of stress types by regulating apoptosis, cell cycle arrest, senescence, DNA repair and genetic stability. For a long time it was thought that these functions of p53 solely rely on its function as a transcription factor, and numerous p53 target genes have been identified [1]. In the last 8 years however, a novel transcription-independent proapoptotic function mediated by the cytoplasmic pool of p53 has been revealed. p53 participates directly in the intrinsic apoptosis pathway by interacting with the multidomain members of the Bcl-2 family to induce mitochondrial outer membrane permeabilization. Our review will discuss these studies, focusing on recent advances in the field.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19007744      PMCID: PMC2819081          DOI: 10.1016/j.bbabio.2008.10.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  61 in total

Review 1.  Mitochondrial membrane permeabilization in cell death.

Authors:  Guido Kroemer; Lorenzo Galluzzi; Catherine Brenner
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

2.  Monoubiquitylation promotes mitochondrial p53 translocation.

Authors:  Natasha D Marchenko; Sonja Wolff; Susan Erster; Kerstin Becker; Ute M Moll
Journal:  EMBO J       Date:  2007-02-01       Impact factor: 11.598

3.  Restoration of p53 function leads to tumour regression in vivo.

Authors:  Andrea Ventura; David G Kirsch; Margaret E McLaughlin; David A Tuveson; Jan Grimm; Laura Lintault; Jamie Newman; Elizabeth E Reczek; Ralph Weissleder; Tyler Jacks
Journal:  Nature       Date:  2007-01-24       Impact factor: 49.962

4.  Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas.

Authors:  Wen Xue; Lars Zender; Cornelius Miething; Ross A Dickins; Eva Hernando; Valery Krizhanovsky; Carlos Cordon-Cardo; Scott W Lowe
Journal:  Nature       Date:  2007-01-24       Impact factor: 49.962

Review 5.  The role of ubiquitination in the direct mitochondrial death program of p53.

Authors:  Natasha D Marchenko; Ute M Moll
Journal:  Cell Cycle       Date:  2007-05-25       Impact factor: 4.534

6.  Mitochondrially targeted wild-type p53 suppresses growth of mutant p53 lymphomas in vivo.

Authors:  G Palacios; U M Moll
Journal:  Oncogene       Date:  2006-05-08       Impact factor: 9.867

7.  Modeling the therapeutic efficacy of p53 restoration in tumors.

Authors:  Carla P Martins; Lamorna Brown-Swigart; Gerard I Evan
Journal:  Cell       Date:  2006-12-21       Impact factor: 41.582

8.  Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation.

Authors:  Evguenia Strom; Swati Sathe; Pavel G Komarov; Olga B Chernova; Ivanda Pavlovska; Inna Shyshynova; Dmitry A Bosykh; Lyudmila G Burdelya; Roger M Macklis; Rami Skaliter; Elena A Komarova; Andrei V Gudkov
Journal:  Nat Chem Biol       Date:  2006-07-23       Impact factor: 15.040

9.  Effect of ischemic preconditioning on mitochondrial dysfunction and mitochondrial p53 translocation after transient global cerebral ischemia in rats.

Authors:  Peter Racay; Zuzana Tatarkova; Anna Drgova; Peter Kaplan; Dusan Dobrota
Journal:  Neurochem Res       Date:  2007-07-28       Impact factor: 3.996

10.  Comparative biophysical characterization of p53 with the pro-apoptotic BAK and the anti-apoptotic BCL-xL.

Authors:  Begona Sot; Stefan M V Freund; Alan R Fersht
Journal:  J Biol Chem       Date:  2007-08-14       Impact factor: 5.157

View more
  240 in total

1.  Functional analysis of the p53 codon 72 polymorphism in black South Africans with rheumatoid arthritis--a pilot study.

Authors:  Devapregasan Moodley; Girish M Mody; Anil A Chuturgoon
Journal:  Clin Rheumatol       Date:  2010-06-10       Impact factor: 2.980

2.  Regulation of p53 stability and function by the deubiquitinating enzyme USP42.

Authors:  Andreas K Hock; Arnaud M Vigneron; Stephanie Carter; Robert L Ludwig; Karen H Vousden
Journal:  EMBO J       Date:  2011-11-15       Impact factor: 11.598

3.  DNA damage response by single-strand breaks in terminally differentiated muscle cells and the control of muscle integrity.

Authors:  P Fortini; C Ferretti; B Pascucci; L Narciso; D Pajalunga; E M R Puggioni; R Castino; C Isidoro; M Crescenzi; E Dogliotti
Journal:  Cell Death Differ       Date:  2012-06-15       Impact factor: 15.828

4.  PP2A:B56{epsilon}, a substrate of caspase-3, regulates p53-dependent and p53-independent apoptosis during development.

Authors:  Zhigang Jin; Lindsay Wallace; Scott Q Harper; Jing Yang
Journal:  J Biol Chem       Date:  2010-08-31       Impact factor: 5.157

5.  Kip3-ing kinetochores clustered.

Authors:  Ryoma Ohi
Journal:  Cell Cycle       Date:  2010-07-01       Impact factor: 4.534

6.  Regulation of mitochondrial apoptotic events by p53-mediated disruption of complexes between antiapoptotic Bcl-2 members and Bim.

Authors:  Jie Han; Leslie A Goldstein; Wen Hou; Brian R Gastman; Hannah Rabinowich
Journal:  J Biol Chem       Date:  2010-04-19       Impact factor: 5.157

Review 7.  p53-mediated neuronal cell death in ischemic brain injury.

Authors:  Li-Zhi Hong; Xiao-Yuan Zhao; Hui-Ling Zhang
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

Review 8.  p53 at a glance.

Authors:  Colleen A Brady; Laura D Attardi
Journal:  J Cell Sci       Date:  2010-08-01       Impact factor: 5.285

9.  p53 opens the mitochondrial permeability transition pore to trigger necrosis.

Authors:  Angelina V Vaseva; Natalie D Marchenko; Kyungmin Ji; Stella E Tsirka; Sonja Holzmann; Ute M Moll
Journal:  Cell       Date:  2012-06-22       Impact factor: 41.582

10.  Proximal events in 7,12-dimethylbenz[a]anthracene-induced, stromal cell-dependent bone marrow B cell apoptosis: stromal cell-B cell communication and apoptosis signaling.

Authors:  Jessica E Teague; Heui-Young Ryu; Michael Kirber; David H Sherr; Jennifer J Schlezinger
Journal:  J Immunol       Date:  2010-08-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.